ACADIA Pharmaceuticals Inc. vs Medtronic PLC — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while Medtronic PLC trades at $90.5 (market cap $116.07B). The key difference: Medtronic PLC is far larger — about 22.9× ACADIA Pharmaceuticals Inc.'s market cap, and Medtronic PLC pays a 3.18% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | MDT | |
|---|---|---|
Market Cap | $5.07B | $116.07B |
Sector | Health | Health |
52-Week High | $29.41 | $105.35 |
52-Week Low | $20.06 | $73.75 |
Enterprise Value | $4.19B | $134.82B |
Dividend Yield | — | 3.18% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →